Invitation to Participate in Two New ILSI HESI DART Surveys

Survey of Predictive Value of Nonclinical Studies for Reproductive Findings in Men. The Developmental and Reproductive Toxicology (DART) Technical Committee at the ILSI Health and Environmental Sciences Institute (HESI) has launched a survey toward understanding the predictivity of adverse findings in nonclinical male fertility studies to clinical outcomes in men. We are seeking data on compounds that showed adverse findings in any nonhuman species and have data available from clinical trials in any male reproduction endpoint. The survey is open to all who are willing to contribute data. To learn more about or to participate in the survey, please contact Connie Chen (cchen@hesiglobal.org).

Survey of Nonclinical Model of Neonatal/Pediatric Therapeutics. The Developmental and Reproductive Toxicology (DART) Technical Committee at the ILSI Health and Environmental Sciences Institute (HESI) has formed a multi-sector workgroup on the best use of nonclinical approaches for neonatal medicine development. The workgroup has designed a survey towards identifying available nonclinical neonatal pediatric models that may inform the efficacy and long-term safety and tolerability of neonatal drug therapy. The survey is open to all researchers across industry, regulatory agencies, and research institutes who are willing to contribute data. To learn more about or to participate in the survey, please contact Connie Chen (cchen@hesiglobal.org). The full survey is also available online (online survey link).

Recent Stories
Announcing the New Teratology Society Innovator Award

FDA Launches Predictive Toxicology Roadmap

PODCAST: Secrets of the Human Brain Revealed: Development, Disease & the Zika Virus